These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1552098)

  • 1. Front-loaded accelerated infusions of tissue plasminogen activator: putting a better foot forward.
    Vaughan DE; Braunwald E
    J Am Coll Cardiol; 1992 Apr; 19(5):1076-8. PubMed ID: 1552098
    [No Abstract]   [Full Text] [Related]  

  • 2. Front-loaded infusion therapy of rT-PA during active menstruation. A case report.
    Lee DW; Garza JL
    Angiology; 1994 Apr; 45(4):311-4. PubMed ID: 8161010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of intravenous thrombolytic therapy in acute myocardial infarction].
    Kanmatsuse K; Kajiwara N
    Nihon Naika Gakkai Zasshi; 1992 Aug; 81(8):1213-7. PubMed ID: 1431461
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
    J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction.
    Tanswell P; Tebbe U; Neuhaus KL; Gläsle-Schwarz L; Wojcik J; Seifried E
    J Am Coll Cardiol; 1992 Apr; 19(5):1071-5. PubMed ID: 1372625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolytic therapy with tissue-type plasminogen activator].
    Toma M; Yamaguchi T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):797-801. PubMed ID: 12436618
    [No Abstract]   [Full Text] [Related]  

  • 8. TNK-tPA: a new thrombolytic for treatment of acute myocardial infarction.
    Johnson TJ
    S D J Med; 2000 May; 53(5):185-6. PubMed ID: 10835948
    [No Abstract]   [Full Text] [Related]  

  • 9. Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.
    Gulba DC; Tanswell P; Dechend R; Sosada M; Weis A; Waigand J; Uhlich F; Hauck S; Jost S; Rafflenbeul W; Lichtlen PR; Dietz R
    J Am Coll Cardiol; 1997 Dec; 30(7):1611-7. PubMed ID: 9385884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraplegia subsequent to administration of tissue plasminogen activator and intravenous heparin following myocardial infarction--a case report.
    DePorto R; Ahn JH; Gianutsos JG
    J Spinal Cord Med; 2000; 23(2):150-2. PubMed ID: 10914357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.
    Cannon CP; Gibson CM; McCabe CH; Adgey AA; Schweiger MJ; Sequeira RF; Grollier G; Giugliano RP; Frey M; Mueller HS; Steingart RM; Weaver WD; Van de Werf F; Braunwald E
    Circulation; 1998 Dec 22-29; 98(25):2805-14. PubMed ID: 9860780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coronary thrombolysis with urokinase and t-PA--comparison of intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):782-9. PubMed ID: 12436616
    [No Abstract]   [Full Text] [Related]  

  • 14. [Increased efficacy of thrombolytic therapy in acute myocardial infarction by improved properties of new thrombolytic agents].
    Huber K
    Wien Klin Wochenschr; 2000 Sep; 112(17):742-8. PubMed ID: 11042902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of double bolus urokinase versus front-loaded alteplase regimen for acute myocardial infarction. Thrombolysis in Myocardial Infarction in Korea (TIMIKO) study group.
    Park SJ
    Am J Cardiol; 1998 Sep; 82(6):811-3, A10. PubMed ID: 9761098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant tissue plasminogen activator (rt-PA): is it the thrombolytic agent of choice for an evolving acute myocardial infarction?
    Sherry S
    Am J Cardiol; 1987 Apr; 59(9):984-9. PubMed ID: 3105303
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thrombolytic (fibrinolytic) agents for treatment of ischemic heart disease].
    Nagao K; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():641-6. PubMed ID: 12735044
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolytic therapy for acute myocardial infarction--round 2.
    Lancet; 1988 Mar; 1(8585):565-7. PubMed ID: 2894496
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostaglandin E1 does not accelerate rTPA-induced thrombolysis in acute myocardial infarction.
    Kleiman NS; Tracy RP; Schaaff LJ; Harris S; Hill RD; Puleo P; Roberts R
    Am Heart J; 1994 Apr; 127(4 Pt 1):738-43. PubMed ID: 8154410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenge of maintaining coronary arterial patency with intravenous heparin following tissue plasminogen activator administration.
    Becker RC; Gore JM
    Cardiology; 1993; 83(1-2):100-6. PubMed ID: 8261475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.